跳至主要内容
临床试验/EUCTR2004-002056-34-GB
EUCTR2004-002056-34-GB进行中(未招募)1 期

Glucocorticosteroid replacement therapy and fibrinolysis in hypopituitarism - Glucocorticoid replacement therapy and fibrinolysis

Bradford Teaching Hospitals NHS Foundation Trust0 个研究点目标入组 15 人开始时间: 2005年2月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Age >18 years
  • ACTH deficiency previously assessed by dynamic testing (eg. insulin stress test).
  • Currently taking replacement with hydrocotisone at optimal replacement dose.
  • prior written informed consent
  • Must be on stable dose of other pituitary replacement hormones where there is documented deficiency.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Subjects requiring systemic steroid therapy
  • Subjects taking high dose hormone replacement therapy or oral contraceptive tablets
  • Subjects who are currenlty pregnant or who have had a recent pregnancy or abortion
  • Subjects with known malignancy
  • Subjects with known coagulopathy
  • Subjects who are currently taking or who have recently taken anticoagulant therapy
  • Asian subjects and patients with diabetes millitus in whom abnormalities of the fibrinolytic system may exist.

研究者

相似试验